Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma × ontuxizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solid Tumor 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Sarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Hairy Cell 1 Intraocular Lymphoma 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Dendritic Cell Sarcoma, Interdigitating 1 Burkitt Lymphoma 1

Interventions

Doxorubicin 71 Ifosfamide 48 Radiotherapy 38 Filgrastim 37 Gemcitabine 32 Cyclophosphamide 31 Etoposide 24 Vincristine 23 pazopanib 20 Docetaxel 20 Cisplatin 19 Trabectedin 18 Carboplatin 15 pembrolizumab 13 Peripheral Blood Stem Cell Transplantation 12 Mesna 12 Sorafenib 11 Melphalan 11 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 eribulin 10 Sirolimus 10 Bevacizumab 10 pegfilgrastim 9 Topotecan 9 Paclitaxel 9 Temozolomide 8 Surgical Procedures, Operative 8 Dactinomycin 8 Radiation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01574716 2019-08-21

SOURCE

Morphotek

Phase 2 Completed

209 enrolled 18 charts

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡